|
ACVR2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.552380E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.63600000000175E-05 |
| Normal-vs-Stage2 |
1.268210E-01 |
| Normal-vs-Stage3 |
2.042400E-03 |
| Normal-vs-Stage4 |
6.899700E-02 |
| Stage1-vs-Stage2 |
6.579000E-01 |
| Stage1-vs-Stage3 |
4.686400E-01 |
| Stage1-vs-Stage4 |
6.988000E-01 |
| Stage2-vs-Stage3 |
4.161000E-01 |
| Stage2-vs-Stage4 |
9.732200E-01 |
| Stage3-vs-Stage4 |
4.357000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.10729999999826E-05 |
| Normal-vs-AfricanAmerican |
3.228000E-02 |
| Normal-vs-Asian |
1.331040E-01 |
| Caucasian-vs-AfricanAmerican |
2.137800E-01 |
| Caucasian-vs-Asian |
6.643400E-01 |
| AfricanAmerican-vs-Asian |
9.880800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.51634999999706E-05 |
| Normal-vs-Female |
2.585200E-01 |
| Male-vs-Female |
2.268500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.194900E-04 |
| Normal-vs-Extreme_Weight |
1.51487999999755E-05 |
| Normal-vs-Obese |
4.639600E-03 |
| Normal-vs-Extreme_Obese |
2.288000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.401400E-01 |
| Normal_Weight-vs-Obese |
3.216800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.322400E-01 |
| Extreme_Weight-vs-Obese |
1.615640E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.380600E-01 |
| Obese-vs-Extreme_Obese |
8.102800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.196600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.034270E-02 |
| Normal-vs-Age(61-80Yrs) |
2.46329999997741E-06 |
| Normal-vs-Age(81-100Yrs) |
2.997800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.547000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.046400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.382200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.702400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.096410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.578800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.604400E-03 |
| Normal-VS-Type2 PRCC |
1.68259961519368E-10 |
| Normal-VS-KIRP CIMP |
7.399600E-01 |
| Normal-VS-Unclassified PRCC |
1.309810E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.85720000045464E-07 |
| Type1 PRCC-VS-KIRP CIMP |
1.327630E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.789400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.648600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.555600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.702400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65110000005519E-07 |
| Normal-vs-N1 |
2.659600E-01 |
| Normal-vs-N2 |
9.010100E-02 |
| N0-vs-N1 |
6.353600E-02 |
| N0-vs-N2 |
4.366800E-01 |
| N1-vs-N2 |
7.430000E-01 |
|
|
